
660.63 Delayed Data As of May 20 | ![]() Today’s Change | 492.13 Today|||52-Week Range 747.42 | +4.61% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $72.6B |
Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown New York 10591-6707 |
Leonard S. Schleifer | Co-President, Chief Executive Officer & Director |
George Damis Yancopoulos | Co-President, Director & Chief Scientific Officer |
Patrice Gilooly | Senior VP-Quality Assurance & Operations |
Robert E. Landry | Chief Financial Officer & Executive VP-Finance |
Neil Stahl | Executive VP-Research & Development |